Jump to navigation
CONFUSION surrounds new regulations for prescribing Di-Gesic and Doloxene (dextropropoxyphene, DPP), despite the latest ruling by the Administrative Appeals Tribunal (AAT).
To continue reading please login or sign up for access.
Neil Bramwell is a regular feature writer and contributor for MO.
More articles by this author >
Cirrus Media is Australia’s premier business to business publisher, delivering the country’s most recognised industry magazines and websites.